Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial

A. van der Hout, C. F. van Uden-Kraan, K. Holtmaat, F. Jansen, B. I. Lissenberg-Witte, G. A. P. Nieuwenhuijzen, J. A. Hardillo, R. J. Baatenburg de Jong, N. L. Tiren-Verbeet, D. W. Sommeijer, K. de Heer, C. G. Schaar, R. J. E. Sedee, K. Bosscha, M. W. M. van den Brekel, J. F. Petersen, M. Westerman, J. Honings, R. P. Takes, I. HoutenbosqW. T. van den Broek, R. de Brees, P. Jansen, S. E. J. Eerenstein, C. R. Leemans, J. M. Zijlstrab, P. Cuijpers, L. V. van de Poll-Franse, I. M. Verdonck-de Leeuw*

*Corresponding author for this work

Research output: Contribution to journalArticleScientificpeer-review

57 Downloads (Pure)

Abstract

Introduction: 

The web-based self-management application Oncokompas was developed to support cancer survi-vors to monitor health-related quality of life and symptoms (Measure) and to provide tailored information (Learn) and supportive care options (Act). In a previously reported randomised controlled trial (RCT), 68% of 655 recruited survivors were eligible, and of those 45% participated in the RCT. Among participants of the RCT that were randomised to the intervention group, 52% used Oncokompas as intended. The aim of this study was to explore reasons for not participating in the RCT, and reasons for not using Oncokompas among non-users, and the use and evaluation of Oncokompas among users.


Original languageEnglish
Article number100429
Number of pages10
JournalInternet Interventions
Volume25
DOIs
Publication statusPublished - 2021

Keywords

  • Cancer survivorship
  • eHealth
  • Web-based intervention
  • Self-management
  • Health-related quality of life
  • QUALITY-OF-LIFE
  • SUPPORTIVE CARE
  • CLINICAL-TRIALS
  • LONG-TERM
  • INTERVENTIONS
  • PATIENT
  • SYMPTOMS
  • PROTOCOL
  • OUTCOMES
  • USAGE

Fingerprint

Dive into the research topics of 'Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial'. Together they form a unique fingerprint.

Cite this